Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Basic Research in Cardiology

• Publication date

  2016-05-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00395-016-0563-4PMID 27234258PMCID PMC5135091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exenatide reverses dysregulated microRNAs in high-fat diet-induced obese mice.

  2016cited by this paper
• Post‐translational modifications of the cardiac proteome in diabetes and heart failure

  2015cited by this paper
• GLP-1 contributes to increases in PGC-1α expression by downregulating miR-23a to reduce apoptosis.

  2015cited by this paper
• miRNA-30 Family Inhibition Protects Against Cardiac Ischemic Injury by Regulating Cystathionine-γ-Lyase Expression

  2015cited by this paper
• Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth Muscle

  2015cited by this paper
• Proteomic Analysis of Cerebrospinal Fluid in Canine Cervical Spondylomyelopathy

  2015cited by this paper
• Obesity-related cardiomyopathy is an adipocyte-mediated paracrine disease.

  2015cited by this paper
• Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry

  2015cited by this paper
• Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin

  2015cited by this paper
• Impact of obesity on cardiac metabolism, fibrosis, and function.

  2015cited by this paper
• Molecular mechanisms of diabetic cardiomyopathy

  2014cited by this paper
• Cardiovascular and hemodynamic effects of glucagon-like peptide-1

  2014cited by this paper
• The impact of obesity and hypoxia on left ventricular function and glycolytic metabolism

  2014cited by this paper
• Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.

  2014cited by this paper
• Glucagon-like peptide-1 (7–36) but not (9–36) augments cardiac output during myocardial ischemia via a Frank–Starling mechanism

  2014cited by this paper
• Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy

  2014cited by this paper
• Systolic and Diastolic Abnormalities Reduce the Cardiac Response to Exercise in Adolescents With Type 2 Diabetes

  2014cited by this paper
• Overview of epidemiology and contribution of obesity to cardiovascular disease.

  2014cited by this paper
• P10 miRNA-30 family inhibition protects against cardiac ischemic injury by regulating cystathionine-gamma-lyase expression

  2014cited by this paper
• Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management.

  2014cited by this paper
• Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4.

  2014cited by this paper
• GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.

  2013cited by this paper
• Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.

  2013cited by this paper
• Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model

  2013cited by this paper
• Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome.

  2013cited by this paper
• miRNA in the regulation of ion channel/transporter expression.

  2013cited by this paper
• Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus

  2013influential reference
• Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

  2013cited by this paper
• The interaction of Ca2+ with sarcomeric proteins: role in function and dysfunction of the heart.

  2012cited by this paper
• Heart of the matter: coronary dysfunction in metabolic syndrome.

  2012cited by this paper
• MicroRNA-15a/b are up-regulated in response to myocardial ischemia/reperfusion injury

  2012cited by this paper
• Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent : In vi o and in vitro data

  2012cited by this paper
• Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family

  2012cited by this paper
• MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

  2012cited by this paper
• MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients

  2012cited by this paper
• The interaction of Ca2+ with sarcomeric proteins: role in function and dysfunction of the heart

  2012cited by this paper
• Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.

  2012cited by this paper
• Inhibition of miR-15 Protects Against Cardiac Ischemic Injury

  2012cited by this paper
• Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome.

  2012cited by this paper
• A cardiac microRNA governs systemic energy homeostasis by regulation of MED13.

  2012influential reference
• Cardiovascular impact of the pediatric obesity epidemic: higher left ventricular mass is related to higher body mass index.

  2011cited by this paper
• The Giant Protein Titin: A Regulatory Node That Integrates Myocyte Signaling Pathways*

  2011influential reference
• Proteomic profiling of the human failing heart after left ventricular assist device support.

  2011cited by this paper
• Proteomics and Mass Spectrometry: What Have We Learned About The Heart?

  2010cited by this paper
• Cardiac titin: a multifunctional giant.

  2010cited by this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cited by this paper
• Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230))

  2010cited by this paper
• Exercise Training and Caloric Restriction Prevent Reduction in Cardiac Ca2+-Handling Protein Profile in Obese Rats

  2010cited by this paper
• Titin phosphorylation: myocardial passive stiffness regulated by the intracellular giant.

  2009cited by this paper
• Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes

  2009cited by this paper
• Impaired function of coronary BK(Ca) channels in metabolic syndrome.

  2009cited by this paper
• Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

  2009cited by this paper
• NFATc2 Is a Necessary Mediator of Calcineurin-dependent Cardiac Hypertrophy and Heart Failure*

  2008cited by this paper
• Proteomic analysis of left ventricular remodeling in an experimental model of heart failure.

  2008cited by this paper
• Mechanisms of Coronary Dysfunction in Obesity and Insulin Resistance

  2007cited by this paper
• Impact of Obesity on Left Ventricular Mass and Function in Subjects With Chronic Volume Overload

  2007cited by this paper
• Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

  2006cited by this paper
• Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism

  2006cited by this paper
• Impact of obesity on long-term prognosis following acute myocardial infarction.

  2005cited by this paper
• A Systematic Characterization of Mitochondrial Proteome from Human T Leukemia Cells*S

  2005cited by this paper
• Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers.

  2005cited by this paper
• Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension

  2004cited by this paper
• Obesity and the risk of death after acute myocardial infarction.

  2004cited by this paper
• Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.

  2004cited by this paper
• Alterations of Left Ventricular Myocardial Characteristics Associated With Obesity

  2004cited by this paper
• Transcriptional regulation by calcium, calcineurin, and NFAT.

  2003cited by this paper
• Statistical significance for genomewide studies

  2003cited by this paper
• Summaries of Affymetrix GeneChip probe level data.

  2003cited by this paper
• Autonomic nervous system functions in obese children.

  2000cited by this paper
• Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy.

  1995cited by this paper
• Development of Short‐term Myocardial Hibernation Its Limitation by the Severity of Ischemia and Inotropic Stimulation

  1993cited by this paper
• The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.

  1991cited by this paper
• Ventricular energetics.

  1990cited by this paper

• Exploring the therapeutic mechanisms of heart failure with Chinese herbal medicine: a focus on miRNA-mediated regulation

  2024cites this paper
• The Impact of Silent Liver Disease on Hospital Length of Stay Following Isolated Coronary Artery Bypass Grafting Surgery

  2024cites this paper
• MicroRNA‐181 in cardiovascular disease: Emerging biomarkers and therapeutic targets

  2024cites this paper
• The miR‐181 family: Wide‐ranging pathophysiological effects on cell fate and function

  2023cites this paper
• Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work

  2023cites this paper
• LncRNA GAS5 Attenuates Cardiac Electrical Remodeling Induced by Rapid Pacing via the miR-27a-3p/HOXa10 Pathway

  2023cites this paper
• Chronic high-rate pacing induces heart failure with preserved ejection fraction-like phenotype in Ossabaw swine

  2022cites this paper
• miR-15b-5p REGULATES THE NLRP3 INFLAMMASOME SIGNAL THROUGH TARGETING SIRT3 TO REGULATE HYPOXIA/REOXYGENATION-INDUCED CARDIOMYOCYTE PYROPTOSIS PROCESS

  2022cites this paper
• Plasma-derived extracellular vesicles transfer microRNA-130a-3p to alleviate myocardial ischemia/reperfusion injury by targeting ATG16L1

  2022cites this paper
• Effects of obesity on the cardiac proteome

  2021cites this paper
• Serum Exosomal microRNA-27-3p Aggravates Cerebral Injury and Inflammation in Patients with Acute Cerebral Infarction by Targeting PPARγ

  2021cites this paper
• MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression

  2021cites this paper
• Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases

  2021cites this paper
• Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in db/db diabetic Mice

  2021cites this paper
• Circulating miR-130 is a potential bio signature for early prognosis of acute myocardial infarction

  2020cites this paper
• Synergistic effects of low-level stress and a Western diet on metabolic homeostasis, mood and myocardial ischemic tolerance.

  2020cites this paper
• Incretins and microRNAs: interactions and physiological relevance.

  2020cites this paper
• Longitudinal modeling using log-gamma mixed model: case of memory deterioration after chronic cerebral hypoperfusion associated with diabetes in rats

  2019cites this paper
• Landscape of heart proteome changes in a diet-induced obesity model

  2019cites this paper
• Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models.

  2019cites this paper
• Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links

  2018cites this paper
• High fat diet reduces the expression of miRNA‐29b in heart and increases susceptibility of myocardium to ischemia/reperfusion injury

  2018cites this paper
• Effect of Caloric Restriction on Metabolic Dysfunction of Young Rapacz Familial Hypercholesterolemic Swine (Sus scrofa).

  2017cites this paper
• Cardiovascular consequences of metabolic syndrome.

  2017cites this paper
• Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction

  2017influential citation
• HEMODYNAMIC AND CARDIAC EFFECTS OF OBESITY AND THE METABOLIC SYNDROME

  2017influential citation